High-throughput Characterization of Fungal Pathogens and Monitoring Phenotypic Drift in Bacteria
September 19, 2024, at 12:00 PM ETAbstract
ATCC, a leading supplier of authenticated biological materials, is partnering with Biolog, Inc. to monitor phenotypic drift in bacterial strains as well as characterize WHO listed fungal pathogens. Understanding the phenotypic profile of a given microbe is key to contextualizing the results of any study. Here, we generated baseline phenotypic profiles for eleven fungal pathogens recognized by the WHO to be of special concern in the global health community and common production and research strains of bacteria. To investigate the occurrence of phenotypic drift in laboratory and production strains we then simulated years of passages while monitoring for changes in each organism's phenotypic profile. Once phenotypic drift was captured, affected generations were then sequenced to ascertain the occurrence of mutations within each strain. This study demonstrated that high-throughput phenotypic screening is a valuable tool for characterizing strains and monitoring phenotypic instability due to genetic changes due to passaging, highlighting the importance of using authenticated strains and minimizing passaging for reliable bioproduction and experiments.
Key Points
- Large-scale phenotypic profiles for emerging and important pathogens using the Odin platform can allow quick identification beyond the species level and thorough metabolic and sensitivity characterization.
- Microorganisms showed genetic variations and significant drift in metabolic and sensitivity phenotypes after as few as 15 passages, which worsened over time.
- Using Odin to monitor the phenotypic stability of production and research strains over time can complement genome sequencing to identify mutations.
Presenter
Max Cravener, PhD
Field Applications Scientist - West, Biolog, Inc.
Dr. Cravener earned a PhD in 2022 from University of Georgia in Microbiology with a focus on fungal genetics. Dr. Cravener worked with Candida albicans studying natural variation among clinical isolates and how gene expression and regulatory differences can impact their ability to form biofilms on implanted medical devices.
Shahin Ali, PhD
Senior Scientist, Collections, ATCC
Dr. Ali is a Senior Scientist at ATCC with over 13 years of experience in the field of fungal biology and plant-pathogen interactions. Before joining ATCC, Dr. Ali worked for the USDA-ARS at Beltsville Agricultural Research Center, Maryland. He obtained his PhD from University College Dublin, Ireland.